Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11122553 | 1.00 | MEN1 (0.46) | MEN1KMT2ATSHRMAPK1POLB | |
| Sulfuric Acid SCHEMBL8491595 | 0.96 | TSHR (0.39) | MEN1KMT2ATSHRMAPK1POLB | |
| Sulfuric Acid SCHEMBL28779586 | 0.94 | TSHR (0.38) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL14696270 | 0.92 | MEN1 (0.42) | MEN1KMT2ATSHRMAPK1POLB | |
| Sulfuric Acid SCHEMBL5612014 | 0.91 | POLB (0.40) | MEN1KMT2ATSHRPOLBALDH1A1 | |
| Sulfuric Acid SCHEMBL324982 | 0.91 | POLB (0.40) | MEN1KMT2ATSHRPOLBALDH1A1 | |
| Sulfuric Acid SCHEMBL3260148 | 0.91 | POLB (0.40) | MEN1KMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL426462 | 0.89 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL426095 | 0.89 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB | |
| SCHEMBL3663413 | 0.89 | MEN1 (0.58) | MEN1KMT2ATSHRMAPK1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 959 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089111-B2 | PROCESS FOR MANUFACTURING CONCENTRATED SURFACTANT COMPOSITIONS | UNILEVER PLC (GB) | 2013-09-04 | — | — | EP | claimed |
| EP-2089111-B1 | PROCESS FOR MANUFACTURING CONCENTRATED SURFACTANT COMPOSITIONS | UNILEVER PLC (GB) | 2010-02-24 | — | — | EP | claimed |
| EP-2089111-A1 | CONCENTRATED SURFACTANT COMPOSITIONS | Unilever PLC (GB) | 2009-08-19 | — | — | EP | claimed |
| US-20080139434-A1 | Concentrated surfactant compositions | CONOPCO INC, D/B/A UNILEVER | 2008-06-12 | — | — | US | claimed |
| WO-2008068222-A1 | CONCENTRATED SURFACTANT COMPOSITIONS | UNILEVER PLC (GB) | 2008-06-12 | — | — | WO | claimed |
| WO-2023220097-A1 | ORGANIC RICINOLEATE SALTS AS DEODORIZING AGENTS | COLONIAL CHEMICAL, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023200773-A1 | COMPOSITIONS HAVING CAPSULES WITH A DUAL SHELL AND A NANOPARTICLE LAYER | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-19 | — | — | WO | disclosed |
| US-20230320949-A1 | Compositions Having Capsules | THE PROCTER & GAMBLE COMPANY | 2023-10-12 | — | — | US | disclosed |
| WO-2023119230-A1 | COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| US-20230190719-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | BIOHAVEN THERAPEUTICS LTD (US) | 2023-06-22 | — | — | US | disclosed |
| EP-4168116-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | Biohaven Therapeutics Ltd. (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-115836052-A | Topical formulations of (1S) -1-phenyl-2-pyridin-2-ylethylamine | 拜尔哈文制药股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| US-4011169-A | USING AN ENZYME AND AMINATED POLYSACCHARIDE | THE PROCTER & GAMBLE COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-4000080-A | ETHYLENE OXIDE CONDENSATION PRODUCT WITH MALEIC ANHYDRIDE-VINYL METHYL ETHER COPOLYMER | THE PROCTER & GAMBLE COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3993573-A | SMECTITE CLAY, CATIONIC ANTISTATIC AGENTS AND ACIDIC COMPATIBILIZING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
| US-3979339-A | POLYVINYL PYRROLIDONE, VINYL ACETATE-VINYL ALCOHOL COPOLYMER | THE PROCTER & GAMBLE COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3970594-A | SURFACTANT, BUILDER, POLYVINYL ALCOHOL OR PYRROLIDONE, POLYSACCHARIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-07-20 | — | — | US | disclosed |
| US-3962152-A | SURFACTANT, ETHYLENE TEREPHTHALATE, POLYETHYLENE OXIDE TEREPHTHALATE | THE PROCTER & GAMBLE COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3954632-A | SMECTITE CLAY, QUATERNARY AMMONIUM ANTISTATIC AGENT, CARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3944470-A | AMINATED POLYSACCHARIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320949-A1 | Compositions Having Capsules | ABCB11, ABCC1, ABCC9 | MEN1 207/4885KMT2A 4370/4885TSHR 4500/4885 |
| US-20230190719-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | TRPV1, PNN, SLC18A2 | MEN1 3089/4885KMT2A 1755/4885TSHR 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.